Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
life sciences
national blog main
san francisco blog main
san francisco top stories
abaloparatide
amgen
avapritinib
blueprint medicines
boston
boston blog main
boston top stories
cstone pharmaceuticals
deals
eli lilly
europe blog main
europe top stories
european commission
european medicines agency
fisogatinib
flatiron health
genentech
hepatocellular carcinoma
investing
jeff albers
medullary thyroid cancer
national
national top stories
non-small cell lung cancer
osteoporosis
pralsetinib
radius health
roche
romosozumab
selpercatinib
teriparatide
thermo fisher scientific
thyroid cancer
What
approval
drug
marketing
2
×
wins
2
×
amgen
amgen’s
blueprint
cancer
candidate
carries
currently
developed
europe
european
fda
heart
medicine
medicines
muscle
nod
osteoporosis
pact
raise
regulatory
ret
review
risk
roche
team
warning
Language
unset
Current search:
wins
×
marketing
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning